LU1803069274 Net Asset Value Analysis

Franklin Biotechnology Discovery A (acc) EUR-H1 (LU1803069274)

17.43 -0.53 (-2.95%) EUR | May 15 2026

Net Asset Value Chart

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Asset Value Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Net Asset Value (NAV) Definition

View Net Asset Value (NAV) Definition

Start Trial

Net Asset Value measures the total value of a security based on assets divided by shares outstanding. This metric is calculated by (Total Assets - Total Liabilities) / Shares Outstanding.

Read full definition.

Net Asset Value Range, Past 5 Years

View Net Asset Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Net Asset Value Benchmarks

View Net Asset Value Benchmarks

Start Trial

Pictet-Biotech-HP EUR	801.78
MEDICAL BioHealth EUR H	775.74
Selectra Investments J. Lamarck Biotech A	453.98
DWS ESG Biotech FC	169.16
Janus Henderson Horizon Biotechnology IU2 HEUR	34.59

Net Asset Value Excel Add-In Codes

View Net Asset Value Excel Add-In Codes

Start Trial

Metric Code: net_asset_value

Latest Data Point: =YCP("M:LU1803069274", "net_asset_value")

Last 5 Data Points: =YCS("M:LU1803069274", "net_asset_value", -4)

To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.